Mesothelioma Cell Types Explained
The types of mesothelioma cells can be significant in a patient’s prognosis and treatment plan. About 60 percent of all mesothelioma cases are epithelioid. This cell type usually has a better prognosis than sarcomatoid, which accounts for about 25 percent of all mesothelioma cases. The remaining 15 percent of cases are biphasic, meaning a patient’s tumor exhibits both epithelioid and sarcomatoid cells. A biphasic diagnosis requires at least 10 percent of each cell pattern to be present in the tumor.
Epithelioid tumors originate in the cells that line an organ, whereas sarcomatoid tumors start growing in the bone or soft tissues. Sarcomatoid cells tend to metastasize faster than epithelioid cells, making epithelioid cases generally more treatable. Most patients with epithelioid tumors undergo a multimodal treatment plan (treatment approach that combines multiple therapies, such as chemotherapy and radiation) to eradicate the cancer.
Visiting a specialist, getting a second opinion, and having a customized treatment plan are of the utmost importance when fighting mesothelioma.
It’s also important to remember that statistics are merely that: statistics. Statistics are numbers based on other patients, other circumstances, and other survival rates. And because mesothelioma is such a rare cancer, these numbers are usually stale. As a patient, attitude matters. Accepting your diagnosis doesn’t mean you must accept your doctor-given prognosis. Many mesothelioma patients have outlived their original prognosis, and treatment options continue to advance as doctors learn more about this rare disease.
Types of Mesothelioma Cells
|60% of cases||25% of cases||15% of cases|
|18-24-month median survival||4-6-month median survival||10-15-month median survival|
How Do I Know What Cell Type I Have?
A biopsy is the only definitive way to confirm a mesothelioma diagnosis and will inform your doctor of what cell type you have. By determining the cell type present in your mesothelial tumor, your doctor can plan the best course of treatment.
Your doctor will consult with a histopathologist (doctor specializing in the study of diseased cells). They will examine the sample of diseased tissue from the biopsy, analyzing the cell structure to determine the type of cells present in the tumor. This information is critical for doctors when crafting a specialized treatment plan.
A histopathologist uses an additional set of diagnostic tests, called immunohistochemistry, or IHC, to diagnose a patient’s mesothelioma cell type. IHC uses antibodies or matching molecules that attach to different cell markers, which are proteins that classify and identify cells. A histologist then adds specific enzymes to the section of diseased tissue to produce different colors. These color changes help doctors further visualize and identify various tissue abnormalities, and can lead to a more precise diagnosis.
Benign Tumors of the Mesothelium
In rare cases, mesothelioma tumors may be considered “benign.” These masses tend to spread slower than malignant mesothelioma tumors. Due to its rarity, doctors and researchers still do not fully understand benign mesothelioma. However, if you are diagnosed with benign mesothelioma, you should still seek treatment as soon as possible to have the tumor(s) removed.
Treatment for mesothelioma is costly. Luckily, the average mesothelioma claim settles between $250,000 and $2,000,000.